[Journal logo]

Volume 64 
Part 10 
Page o2042  
October 2008  

Received 17 September 2008
Accepted 25 September 2008
Online 30 September 2008

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.004 Å
R = 0.047
wR = 0.135
Data-to-parameter ratio = 13.1
Details
Open access

Ethyl 1-(4-chlorophenyl)-3-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]-2-nitro-2,3,10,10a-tetrahydro-1H,5H-pyrrolo[1,2-b]isoquinoline-10a-carboxylate

aCentre of Advanced Study in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai 600025, India,bDepartment of Physics, Presidency College (Autonomous), Chennai 600005, India, and cDepartment of Organic Chemistry, University of Madras, Guindy Campus, Chennai 600025, India
Correspondence e-mail: mnpsy2004@yahoo.com

In the title compound, C37H34ClN3O6, the pyrrolidine and piperidine rings adopt envelope and boat conformations, respectively. The [beta]-lactam ring is planar and forms dihedral angles of 21.3 (2) and 73.9 (2)°, respectively, with the attached methoxyphenyl and phenyl rings. Intramolecular C-H...O and C-H...N hydrogen bonds are observed. Centrosymmetrically related molecules are linked together by weak C-H...O hydrogen bonds to form dimers.

Related literature

For the biological properties of [beta]-lactam derivatives, see: Borthwick et al. (1998[Borthwick, A. D., Weingarte, G., Haley, T. M., Tomaszewski, M., Wang, W., Hu, Z., Bedard, J., Jin, H., Yuen, L. & Mansour, T. S. (1998). Bioorg. Med. Chem. Lett. 8, 365-370.]); Brakhage (1998[Brakhage, A. A. (1998). Microbiol. Mol. Biol. Rev. 62, 547-585.]); Burnett (1994[Burnett, D. A. (1994). Tetrahedron Lett. 35, 7339-7342.]); Han et al. (1995[Han, W. T., Trehan, A. K., Wright, J. J. K., Federici, M. E., Seiler, S. M. & Meanwell, N. A. (1995). Bioorg. Med. Chem. Lett. 3, 1123-1143.]); Vaccaro & Davis (1998[Vaccaro, W. D. & Davis, H. R. Jr (1998). Bioorg. Med. Chem. Lett. 8, 313-318.]); Vaccaro et al. (1998[Vaccaro, W. D., Sher, R. & Davis, H. R. Jr (1998). Bioorg. Med. Chem. Lett. 8, 35-40.]). For puckering and asymmetry parameters, see: Cremer & Pople (1975[Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.]); Nardelli (1983[Nardelli, M. (1983). Acta Cryst. C39, 1141-1142.]).

[Scheme 1]

Experimental

Crystal data
  • C37H34ClN3O6

  • Mr = 652.12

  • Monoclinic, P 21 /n

  • a = 9.1723 (2) Å

  • b = 18.0452 (4) Å

  • c = 19.7475 (5) Å

  • [beta] = 100.638 (1)°

  • V = 3212.35 (13) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.17 mm-1

  • T = 293 (2) K

  • 0.22 × 0.20 × 0.17 mm

Data collection
  • Bruker kappa APEXII area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 2001[Sheldrick, G. M. (2001). SADABS. University of Göttingen, Germany.]) Tmin = 0.963, Tmax = 0.971

  • 30325 measured reflections

  • 5582 independent reflections

  • 3760 reflections with I > 2[sigma](I)

  • Rint = 0.034

Refinement
  • R[F2 > 2[sigma](F2)] = 0.047

  • wR(F2) = 0.135

  • S = 1.02

  • 5582 reflections

  • 426 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.34 e Å-3

  • [Delta][rho]min = -0.27 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
C2-H2A...N27 0.97 2.53 3.196 (3) 126
C24-H24...O3 0.98 2.58 3.186 (3) 121
C25-H25...O6i 0.98 2.60 3.479 (3) 150
C35-H35...O5 0.93 2.60 3.157 (3) 119
C40-H40A...O4i 0.96 2.49 3.232 (4) 134
Symmetry code: (i) -x, -y+1, -z.

Data collection: APEX2 (Bruker, 2004[Bruker (2004). SAINT and APEX2. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2004[Bruker (2004). SAINT and APEX2. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2003[Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: CI2676 ).


Acknowledgements

SS thanks Dr Babu Varghese, SAIF, IIT Madras, Chennai, India, for his help with the data collection.

References

Borthwick, A. D., Weingarte, G., Haley, T. M., Tomaszewski, M., Wang, W., Hu, Z., Bedard, J., Jin, H., Yuen, L. & Mansour, T. S. (1998). Bioorg. Med. Chem. Lett. 8, 365-370.  [CrossRef] [ChemPort] [PubMed]
Brakhage, A. A. (1998). Microbiol. Mol. Biol. Rev. 62, 547-585.  [ChemPort] [PubMed]
Bruker (2004). SAINT and APEX2. Bruker AXS Inc., Madison, Wisconsin, USA.
Burnett, D. A. (1994). Tetrahedron Lett. 35, 7339-7342.  [CrossRef] [ChemPort]
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.  [CrossRef] [ChemPort] [ISI]
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Han, W. T., Trehan, A. K., Wright, J. J. K., Federici, M. E., Seiler, S. M. & Meanwell, N. A. (1995). Bioorg. Med. Chem. Lett. 3, 1123-1143.  [ChemPort]
Nardelli, M. (1983). Acta Cryst. C39, 1141-1142.  [CrossRef] [details]
Sheldrick, G. M. (2001). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.  [CrossRef] [details]
Vaccaro, W. D. & Davis, H. R. Jr (1998). Bioorg. Med. Chem. Lett. 8, 313-318.  [CrossRef] [ChemPort] [PubMed]
Vaccaro, W. D., Sher, R. & Davis, H. R. Jr (1998). Bioorg. Med. Chem. Lett. 8, 35-40.  [CrossRef] [ChemPort] [PubMed]


Acta Cryst (2008). E64, o2042  [ doi:10.1107/S1600536808030961 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.